COVID-19 Vaccine Attitude and Its Predictors Among People Living With Chronic Health Conditions in Ibadan, Nigeria

Abstract

Objective: To assess vaccination attitude and its associated factors among people with chronic health conditions.

Methods: In this cross-sectional study, participants were 423 patients with chronic medical conditions. Data were collected on socio-demographic and COVID-19-related characteristics, via Open Data Kit software. A Vaccination Attitudes Examination (VAX) Scale was adopted. The main outcome was vaccine attitude status defined as positive if a VAX sum score was above the median value; otherwise, non-positive. Data were analysed using Chi-square and multivariate logistic regression analyses, at 5% level of significance.

Results: Overall proportion of patients with a positive attitude towards COVID-19 vaccination uptake was 46.6%. The most influential factor towards positive attitude was rating the government high in handling the pandemic. Other factors were education, income, COVID-19 knowledge and living room arrangement (p < 0.05).

Conclusion: Less than half of people living with a chronic medical condition had a positive attitude towards the COVID-19 vaccine. The attitudes are strongly mediated by confidence in the government. The government could promote a positive vaccine attitude by improving the clarity of health instructions that shows government transparency and effective communication. These are critical tools for maintaining public trust and confidence.

Introduction

The impact of the COVID-19 pandemic on social, economic and political life is unprecedented. Lockdown was imposed in several countries to guarantee limited contact between individuals and to ensure that citizens observed social distancing, which admissibly helped curtail virus transmission [1]. However, countries suffered massive economic losses [2]. This led to easing the lockdown which soon increased COVID-19 infection and mortality [3]. The health system has not been able to effectively cater for the needs of those suffering from Acute Respiratory Distress (ARD) and SARS-CoV-2 cases of pneumonia, especially in Africa [4]. Consequently, efforts to prevent further transmission through the development of vaccines became inevitable. Vaccine development was seen as crucial to ending the pandemic [5]. As of late February 2021, COVID-19 vaccines were already available and were being administered to people mostly in high-income countries like the United Kingdom, United States, Canada, and China, among others [6]. In line with this and the effort by the World Health Organisation to ensure that the vaccines get to low- and middle-income countries, there is a need to ensure that it is well received by the general population, particularly those with chronic conditions.

Nonetheless, vaccine availability does not necessarily translate to the uptake. It has been suggested that apart from prioritizing vaccine administration, other important factors that would affect vaccine distribution include the capability of the health system in ensuring that the vaccines are made available for people at high risk and the willingness of the people to be vaccinated [7]. Despite the fatality of COVID-19 and the purported success in developing vaccines, a sceptical attitude continues to trail vaccination in many countries of the world, including developed countries. This phenomenon sometimes referred to as ‘vaccine hesitancy, has been reported in many countries largely due to vaccine disinformation [8, 9] and misinformation [10]. Latkin et al. (2021) reported that 40.9% of adults in the US mistrusted the vaccine while 16% of adults in the UK had a high level of mistrust, towards the vaccine [11]. Also, 69% of adult participants were willing to get vaccinated in a study among over 2000 adults in the US [12]. The proportion of people intending to get vaccinated is similar to that reported among about a thousand Hong Kong nurses [1]. Other authors have reported varying percentages in different African countries. These include 59% among Ethiopian health practitioners [13]; 44% and 51% among the general population of adults in Egypt and Ghana respectively [14, 15].

It was opined that the proportion of vaccinated people should be greater than two-thirds to achieve “herd” or public immunity [1]. Literature has shown that reasons for unwillingness to vaccinate, mistrust of vaccines and poor vaccine intention include low socioeconomic status, lower education, older age, concerns about the unforeseen side effects, mistrust of Government, poor adherence to COVID-19 prevention guidelines, being male, being unmarried, religious beliefs and social media influence [1, 5, 10, 11, 13, 15].

Addressing the aforementioned factors may promote a positive attitude and high intention to be vaccinated. Besides, COVID-19 vaccine recommendation by health care providers was a positive mediating factor towards its uptake among participants in several low- and middle-income countries [16] and among US adults [12]. Adequate understanding of clients by health care professionals is therefore crucial before they can effectively communicate the need for vaccines [17]. Nurses, physicians and other health care workers can thus effectively improve the attitude and uptake of the vaccine among their clients.

Generally, the population at higher risk of death or complications should be vaccinated first due to an inadequate supply of COVID-19 vaccine. Many countries have therefore adopted the WHO vaccination guideline of prioritizing people at higher risk of mortality from the disease including older adults and those with chronic conditions like diabetes and chronic kidney disease [18].

Specifically, adults with a chronic condition are more likely to be hospitalized due to COVID-19 infection compared to healthy individuals in a study conducted in the United States [19]. For example, having diabetes increases the risk of developing COVID-19 as well as increasing the risk of dying from COVID-19 complications [20]. Studies in Africa including Nigeria have also corroborated the claim that people who have co-morbidities such as diabetes and hypertension are more likely to suffer fatality from COVID-19 infection [21].

In a study conducted among Ethiopians living with diabetes and hypertension, many participants (79%) felt that they were more susceptible to COVID-19 death, yet only 10% were involved in a good level of COVID-19 prevention measures [22]. The poor attitude towards COVID-19 prevention could be carried over to the reception of the vaccine. Hence, the need to assess vaccination attitude.

Many studies have examined the COVID-19 vaccination attitude but few were conducted in Nigeria among people with chronic conditions. The attitude towards vaccination and its associated factors may differ considerably in Nigeria. While most studies have focused on the general population [9, 11, 12, 23] others have examined the phenomenon among specific populations including nurses [1] and students [24]. But there is a need to ascertain the attitude of people living with chronic conditions including diabetes, hypertension and chronic kidney disease towards vaccination since they are among the COVID-19 infection susceptible population for the uptake of the COVID-19 vaccine. . Against this background, the study aimed at assessing the COVID-19 vaccine attitude among persons living with chronic health conditions, receiving treatment in University College Hospital Ibadan, Nigeria, and to determine its associated factors.

Methods

The Study Design and Setting

A cross-sectional study on attitude and intention to COVID-19 vaccine uptake among people living with chronic health conditions in Ibadan, Nigeria was conducted between March and April 2021. This study is part of a larger study on “COVID-19 Vaccine: Attitude, Intention to Vaccinate, Mediating Factors and Interventions towards a Positive Attitudes among People with Chronic Conditions in Ibadan”. The present study was conducted at the Medical Outpatient Clinic of the University College Hospital (UCH), Ibadan, Oyo State, Nigeria. The UCH is a tertiary health care facility which specialises in all disease conditions and receives referrals from secondary health facilities within and outside Oyo State. Eligible consenting patients were referred to participate by Counselors after routine patients’ education sessions during which information about the study was provided to all clinic attendees. On average, 20 participants were expected on each clinic day for the 2 months of data collection.

Sample Size Determination and Sampling Strategy

Based on the assumptions of a 50% prevalence of positive attitude towards the uptake of COVID-19 vaccination among the patients and a 5% desired level of precision, the required minimum sample size was estimated. The assumed 50% prevalence was adopted since no other studies had been conducted in Nigeria, as of February 2021 when the study protocol was developed, to show the composite level of attitude to COVID-19 vaccine uptake. A total of 423 sample size was then estimated for the study after adjusting for a 10% non-response rate. At every clinic visit, eligible consenting participants were selected using a simple random sampling (balloting approach), conducted by researchers. Daily attendance register at the Record section of the clinic served as the sampling frame. Of 40 secret ballot papers, labelled “yes” or “no” prepared for eligible patients who registered on a clinic day, 20 were “yes.” A patient who selected a “yes” was enrolled on the study after written informed consent was obtained while excluding patient who was very ill and cognitively impaired.

Data Collection

Data collection took place before the vaccination of the general population commenced in Nigeria. Data were collected on socio-demographic variables and COVID-19-related characteristics among the patients by trained research assistants. The interviewers who were postgraduate students in the College of Medicine were trained at a one-day workshop. During the training, they got general orientation about the study objectives, interviewing skills and health research ethics. Each question item was explained as well as how to record the responses.

A questionnaire consisting of three [3] sections was used for data collection. The first section consisted of sociodemographic data and predictors of vaccination attitude, based on a literature search. Items included were gender, age, socioeconomic status using the wealth index [25], employment classification, history of children’s vaccination, daily exposure to news, and self-rated adherence to the COVID-19 guidelines, among others.

The second section was made up of the Vaccine Attitude Examination (VAX) Scale. The VAX scale is a 12-item scale [26]. The scale consisted of four subscales which provide information on individuals with vaccination resistance. The subscales are 1) mistrust of vaccine benefits 2), worries about unforeseen future effects 3), concerns about commercial profiteering, and 4) preference for natural immunity. A sufficient convergent validity and internal reliability (Cronbach’s alphas = 0.77–0.93) had been established for all four subscales [26]. The scale is rated on a six-point Likert scale (very strongly disagree (coded as 0), strongly disagree (coded as 1), disagree (coded as 2), agree (coded as 3), strongly agree (coded as 4) and very strongly agree (coded as 5). With a maximum possible score of 60, the overall score was dichotomized using the median value as a cut-off value.

The last section was made up of questions to ascertain contextual influences on COVID-19 vaccine attitude. It was made up of 16 items with three main options: “Yes/No/Not sure.”.

Data Processing and Analysis

The analysis started with data cleaning to ensure completeness and consistency. The main outcome variable was attitude towards the uptake of the COVID-19 vaccine. The response to the attitude questions was summed together to generate an attitude score ranging from 0 to 60. Similar scores (ranged 0–15 scores) were generated for each of the four subscales of attitude toward COVID-19 vaccine uptake. Having confirmed the nonnormality of the outcome variable including its subscales’ scores using the Shapiro Wilk normality test (p < 0.05), an overall score above the median value was coded “1” as a positive attitude; otherwise, coded “0” as non-positive [27]. Independent variables considered were socio-demographics, contextual and COVID-19-related characteristics, see Table 1.

Descriptive statistics such as percentages were used to report the frequency distribution and prevalence of the overall positive attitude towards the uptake of the COVID-19 vaccine, including its four subscales, by the independent characteristics. Chi-squared and Fisher exact tests (where applicable) were performed to assess the individual association of selected background characteristics with the positive attitude towards COVID-19 vaccine uptake in each of the subscales. All factors significantly (p < 0.25) associated with a positive attitude towards COVID-19 vaccination at the bivariate level were thereafter included at the multivariate stage. The logistic regression was used to determine the influence of selected background characteristics on the positive attitude towards COVID-19 vaccine uptake. The adjusted odds ratios (aORs) including their 95% confidence intervals (CIs) and/or p-values are reported. Data management and analysis were conducted using Stata version 14.0 statistical software at a 5% level of significance.

Ethical Approval

The University of Ibadan/University College Hospital Institutional Review Committee approved the survey protocol with approval number UI/EC/21/0065. Participants gave informed consent and were briefed on their freedom to withdraw from the interview at any point, before data collection. Every tenet of the Helsinki declaration and other ethical requirements were strictly complied with throughout the study. No identifying information was collected from participants and study questionnaires were accessible to only investigators and authorised research staff.

Results

Participants’ Characteristics

The participants’ mean age was 54.3 (standard deviation [SD]: 16.3) years. Most participants were aged 50–64 years (35.7%), women (58.2%) and Yoruba (91.3%). Only about 8.0% of respondents earned less than the national minimum wage and 8.5% had no formal education. Most participants reported single health conditions (88.7%) (Table 2).

Hypertension (n = 116; 27.4%), diabetes mellitus (n = 93; 22.0%) and heart conditions/diseases (n = 83; 19.6%) were the top three conditions (see Figure 1).

FIGURE 1

As shown in Table 3, a majority (84.9%) of the participants rated their COVID-19 knowledge high while several (59.3%) had poor adherence to the COVID-19 prevention protocol. Just over half (52.0%) had high confidence in the government while a greater percentage had high confidence in health care workers (79.7%).

Table 4 shows that the proportion of positive attitudes towards COVID-19 vaccine uptake increased with increasing respondents’ age and levels of confidence in government handling the pandemic, in each of the subscales. Overall, less than half of the respondents (46.6%) had a positive attitude towards the uptake of the COVID-19 vaccine. Almost an equivalent proportion of participants had a positive attitude relating to COVID-19 vaccination against worries about unforeseen future effects (46.6%) and preferences for natural immunity (45.9%); 29.6% against mistrust of vaccine benefits and 11.1% were concerned about commercial profiteering.

Factors Influencing Positive Attitude Towards COVID-19 Vaccination Among People Living With Chronic Health Conditions

The adjusted associations of positive attitude towards COVID-19 uptake with significant characteristics (p < 0.25) at the bivariate level, including the attitude subscales set out in Models 1–4, are presented in Table 5. In the overall model, the likelihood of having a positive attitude towards COVID-19 vaccine uptake was higher among patients living in a house with more than two rooms (3-4 rooms—aOR = 3.16, CI: 1.52, 6.57; >4 rooms—aOR = 4.29, CI: 1.87, 9.87) and those who rated government high (aOR = 15.78, CI:6.52, 38.16) at handling the pandemic. The odds of a positive attitude was decreased among patients who had primary education (aOR = 0.28; CI: 0.10, 0.84) and those who had a high level of adherence to COVID-19 preventive measures (aOR = 0.50; CI: 0.29, 0.86). In all the models, patients who rated the government’s handling of the pandemic high were more likely to have a positive attitude toward COVID-19 vaccination. Additionally, patients who owned multiple assets were more likely to have a trust of vaccine benefits (see, model 1). Patients who had formal education were more worried about unforeseen future effects of the COVID-19 vaccine. Residents of a house with more than four rooms were less worried about unforeseen future effects (see, model 2). Living in a house of more than four rooms significantly lowered concerns about commercial profiteering (see, model 3). Patients who practised unhygienic waste disposal (aOR = 2.17; CI:1.25, 3.77) had lower odds of preferences for natural immunity. The odds of preferences for natural immunity were increased among patients who earned more than #30,000 and among those who had better adherence to COVID-19 preventive measures (aOR = 0.44; CI: 0.26, 0.73) (see, model 4, Table 5).

Discussion

We determined COVID-19 vaccination attitude and the predictors among people living with chronic medical conditions in Ibadan, Nigeria. In Nigeria, researchers have assessed COVID-19 vaccine attitude among students [24], acceptance among the general populace [23, 28–30], hesitance among university community [31], perception and willingness to pay among community members [32] or willingness to uptake among health workers [33]. However, none has reported the vaccination attitude among people living with chronic conditions. This study, therefore, stands in the frontline to assess COVID-19 vaccine attitude and its determinants among patients living with chronic health conditions in Nigeria.

In this study, less than half of the participants had a positive attitude towards vaccine uptake. The relatively low level of positive attitude to vaccinate among the population group suggests vaccine hesitancy which may hinder herd immunity. Interestingly, the percentage reported is comparable to that reported among health workers and the general population in Nigeria [23, 33]. It was however higher than the percentage reported among staff and students of a tertiary institution in south-east Nigeria [31]. Compared to other African countries, the proportion reported in this study is lower than that reported in Ethiopia (59%) [34] and comparable to that of Egypt (44%) [14] and Ghana (51%) [15]; however, it was higher than the percentage reported in Kuwait (24%) [35]. In contrast, some studies have shown that participants in high-income countries had a higher percentage of positive attitudes toward vaccine uptake [11, 36]. This could be associated with a greater trust in the vaccine because of the local production of vaccines in those countries. Another plausible reason for the low percentage of positive attitudes towards the vaccine among the studied participants could be linked to the fear of side effects [24]. Fear of vaccine side-effects may therefore be an important predictor of vaccine uptake. Hence, there is a need for aggressive advocacy interventions that offer information on the uptake of the vaccine’s safety and efficacy, especially among the population at high risk.

The most influential factor in having a positive attitude towards the COVID-19 vaccine among the study participants was trust in the government’s ability to handle the pandemic. Those who trusted the government were sixteen times more likely to take the vaccine. This element of trust in the government was much stronger than the influence of confidence in health professionals. Generally, many people think, justifiably so, that the government has a lot to do in helping to manage the pandemic. Not surprising, in many other countries including Nigeria, the government was responsible for imposing curfews, ensuring COVID-19 testing, establishing isolation centres and procuring vaccines for the people. In the USA, the influence of the government had been documented before the COVID-19 pandemic as a significant predictor of flu vaccination [37]. It has also been reported to impact the COVID-19 vaccination attitude among Ireland and UK citizens [38]. This finding corroborates a study conducted among US, Australian and UK citizens [39].

Trust in the government and its influence on vaccination attitude does appear to be a common phenomenon among people across the globe. This was the case in a large intercontinental study involving twenty-six adults [14]. Likewise, another study [40] reported the influence of mistrust of the government on vaccine attitude. There is currently no health condition that has generated so much media attention, controversy/strongly polarised opinion and political involvement as issues surrounding the COVID19 pandemic. Hence, the citizens look up to authorities such as the government to resolve doubts and provide guidelines for the people. This view was supported by Soares et al [41] in a study among the general Portuguese population. Park et al. [42] also reported the negative influence of mistrust in government on vaccination attitudes among South Korean adults. Association of low level of confidence in government handling the pandemic and low level of positive vaccine attitude may result in unwillingness to vaccinate or uptake refusal [11]. It is therefore a matter of necessity that the government and her agencies further strategies to continually gain confidence and build trust in her citizenry for effective uptake of the COVID-19 vaccine in Nigeria.

Socio-economic status based on having more than two rooms in the house was associated with an overall positive attitude towards the vaccine. Similarly, those who owned multiple assets had a positive attitude and were more likely to trust vaccine benefits. These results align with the findings of other studies [2, 11, 43]. Socio-economic status was however not associated with COVID-19 vaccination attitude among older adults in the UK [44]. On the other hand, people of lower socioeconomic status as shown by having fewer assets, lower income and unhygienic waste disposal, which is common among those who live in urban slums, preferred the vaccine to their natural immunity. It is possible that this group of people could not afford a good diet and felt that their immune system was not strong enough to withstand COVID-19 infection [45, 46].

Patients who adhered more to the COVID-19 preventive guidelines had a lowered positive attitude towards the COVID-19 vaccine, but they were more likely to prefer natural immunity to the vaccine. This could be associated with their perceived belief that they would not contract the infection by meticulously following preventive measures. Perception of high COVID-19 risk has been reported to be associated with willingness to take the vaccine among health workers in Nigeria [33]. Our result is in contrast with that of Paul et al. [11] who reported a high level of trust in the COVID-19 vaccine among adults in the UK and with high adherence to COVID-19 measures. By implication, non-positive attitudes towards vaccine may stimulate vaccine mistrust and vaccine hesitancy. These may consequently hinder the attainment of general population immunity. Hence, enlightenment campaigns should be aimed at addressing these concerns.

The study further showed that participants who did not complete their children’s immunization showed a preponderance for natural immunity. This, however, poses a question of how far a person’s natural immunity can protect against the COVID virus. This is an aspect that requires exploration to get to the root of vaccine hesitancy. Recently, The British Society for Immunology in collaboration with the UK Coronavirus Immunology Consortium (UK-CIC) has stated that vaccination against COVID-19 is likely to lead to a more effective and longer-lasting immunity than that prompted by natural infection with the virus. The vaccine is also said to be five times more protective against the virus compared to natural immunity following the infection [47]. Participants who rated their COVID-19 knowledge high were not likely to be concerned about commercial profiteering through the vaccine. This is very likely because many might have sought information about the infection including the vaccine and were convinced of the genuineness of the manufacturers. Hong et al. [48] reported the influence of COVID-19 vaccine knowledge on vaccine acceptance. In view of the present study, the effect of COVID-19 knowledge on vaccine attitude substantially changed after controlling for other covariates. This indicates that having a good knowledge of COVID-19 disease alone may not have contributed to the relatively low levels of mistrust of vaccine benefits and concerns about future unforeseen side effects among people living with chronic health conditions in Nigeria.

The study further showed that participants who did not complete their children’s immunization showed a preponderance for natural immunity. This, however, poses a question of how far a person’s natural immunity can protect against the COVID-19 virus. This is an aspect that requires exploration to get to the root of vaccine hesitancy. Recently, The British Society for Immunology in collaboration with the UK Coronavirus Immunology Consortium (UK-CIC) has stated that vaccination against COVID-19 is likely to lead to a more effective and longer-lasting immunity than that prompted by natural infection with the virus. The vaccine is also said to be five times more protective against the virus compared to natural immunity following the infection [47]. However, the association becomes nonsignificant when other covariates were controlled for.

Conclusion

Less than half of people living with chronic conditions in Ibadan Southwest Nigeria had a positive attitude towards the COVID-19 vaccine, suggesting a relatively low level of potential vaccine uptake. Their attitude was largely influenced by confidence in the government’s ability to handle the pandemic. Other mediating factors toward positive vaccine attitude were high socioeconomic status, poor adherence to COVID-19 preventive measures and having had no formal education. The findings may contribute to developing a strategy for controlling the pandemic by addressing factors significantly affecting vaccination attitude. It is therefore important to design a holistic strategy to promote the uptake of the COVID-19 vaccine, especially among people living with chronic conditions and other high-risk populations. This should include, in the first place, the government’s effort to create and maintain the trust of the citizens. Other measures could include targeting people of low socioeconomic and literacy levels.

Recommendations/Implication

A low level of a positive attitude toward COVID-19 vaccines suggests a substantial barrier to attaining the vaccination uptake and coverage needed for herd immunity. Interventions to promote a positive attitude among people living with chronic conditions should consider factors such as socio-economic status, level of adherence to COVID-19 preventive measures and educational attainment. More importantly, the development of strategies demonstrating government capability at handling the pandemic and at gaining the citizenry’s trust will be critical for effective coverage and uptake of COVID-19 vaccines.

Limitations

Data were collected from a single study setting and the observed attitudes may be biased towards those who have a good health seeking behavior.

Suggestions for Further Study

A qualitative study on the reasons for poor vaccine attitude.

References

• 1

  Kwok KO Li KK Wei WI Tang A Wong SYS Lee SS . Influenza Vaccine Uptake, COVID-19 Vaccination Intention and Vaccine Hesitancy Among Nurses: A Survey. Int J Nurs Stud (2021) 114.

  • Google Scholar

• 2

  Thunström L Newbold SC Finnoff D Ashworth M Shogren JF . The Benefits and Costs of Using Social Distancing to Flatten the Curve for COVID-19. J Benefit Cost Anal (2020) 11(2):179–95. 10.1017/bca.2020.12

  • CrossRef
  • Google Scholar

• 3

  Hussein NR Naqid IA Saleem ZSM Almizori LA Musa DH Ibrahim N . A Sharp Increase in the Number of COVID-19 Cases and Case Fatality Rates after Lifting the Lockdown in Kurdistan Region of Iraq. Ann Med Surg (2020) 57:140–2. 10.1016/j.amsu.2020.07.030

  • CrossRef
  • Google Scholar

• 4

  Ohia C Bakarey AS Ahmad T . COVID-19 and Nigeria: Putting the Realities in Context. Int J Infect Dis (2020) 95:279–81. 10.1016/j.ijid.2020.04.062

  • CrossRef
  • Google Scholar

• 5

  Latkin CA Dayton L Yi G Konstantopoulos A Boodram B . Trust in a COVID-19 Vaccine in the U.S.: A Social-Ecological Perspective. Soc Sci Med (2021) 270:113684. 10.1016/j.socscimed.2021.113684

  • CrossRef
  • Google Scholar

• 6

  Ritchie H Mathieu E Rodés-Guirao L Appel C Giattino C Ortiz-Ospina E et al (2020). Coronavirus (COVID-19) Vaccinations. Available from: https://ourworldindata.org/covid-vaccinations#citation (Accessed on FEB 15, 2021).

  • Google Scholar

• 7

  de Figueiredo A Simas C Karafillakis E Paterson P Larson HJ Dariya B et al Mapping Global Trends in Vaccine Confidence and Investigating Barriers to Vaccine Uptake: a Large-Scale Retrospective Temporal Modelling Study. Lancet (2020) 396(10255):898–908. 10.1016/S0140-6736(20)31558-0

  • CrossRef
  • Google Scholar

• 8

  Dubé E Gagnon D Ouakki M Bettinger JA Guay M Halperin S et al Understanding Vaccine Hesitancy in Canada: Results of a Consultation Study by the Canadian Immunization Research Network. PLoS One (2016) 11(6):e0156118–16. 10.1371/journal.pone.0156118

  • CrossRef
  • Google Scholar

• 9

  Fisher KA Bloomstone SJ Walder J Crawford S Fouayzi H Mazor KM . Attitudes toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults. Ann Intern Med (2020) 173:964–73. 10.7326/M20-3569

  • CrossRef
  • Google Scholar

• 10

  Moola S Gudi N Nambiar D Dumka N Ahmed T Sonawane IR et al A Rapid Review of Evidence on the Determinants of and Strategies for COVID-19 Vaccine Acceptance in Low-And Middle-Income Countries. J Glob Health (2021) 11:5027. 10.7189/jogh.11.05027

  • CrossRef
  • Google Scholar

• 11

  Paul E Steptoe A Fancourt D . Attitudes towards Vaccines and Intention to Vaccinate against COVID-19: Implications for Public Health Communications. Lancet Reg Health Eur (2021) 1:100012. 10.1016/j.lanepe.2020.100012

  • CrossRef
  • Google Scholar

• 12

  Reiter PL Pennell ML Katz ML . Acceptability of a COVID-19 Vaccine Among Adults in the United States: How many People Would Get Vaccinated?Vaccine (2020) 38(42):6500–7. 10.1016/j.vaccine.2020.08.043

  • CrossRef
  • Google Scholar

• 13

  Abay ES Belew MD Ketsela BS Mengistu EE Getachew LS Teferi YA et al Assessment of Attitude towards COVID-19 Vaccine and Associated Factors Among Clinical Practitioners in Ethiopia: A Cross-Sectional Study. PLoS One (2022) 17(6):e0269923. 10.1371/journal.pone.0269923

  • CrossRef
  • Google Scholar

• 14

  Mannan KA Farhana KM . Knowledge, Attitude and Acceptance of a COVID-19 Vaccine: A Global Cross-Sectional Study. SSRN J (2021) 6. 10.2139/ssrn.3763373

  • CrossRef
  • Google Scholar

• 15

  Acheampong T Akorsikumah EA Osae-Kwapong J Khalid M Appiah A Amuasi JH . Examining Vaccine Hesitancy in Sub-saharan Africa: A Survey of the Knowledge and Attitudes Among Adults to Receive COVID-19 Vaccines in Ghana. Vaccines (Basel) (2020) 9:814. 10.3390/vaccines9080814

  • CrossRef
  • Google Scholar

• 16

  Solís Arce JS Warren SS Meriggi NF Scacco A McMurry N Voors M et al COVID-19 Vaccine Acceptance and Hesitancy in Low- and Middle-Income Countries, and Implications for Messaging. Nat Med (2021) 27. 10.1101/2021.03.11.21253419

  • CrossRef
  • Google Scholar

• 17

  Su Z Wen J Abbas J McDonnell D Cheshmehzangi A Li X et al A Race for a Better Understanding of COVID-19 Vaccine Non-adopters. Brain Behav Immun Health (2020) 9:100159. 10.1016/j.bbih.2020.100159

  • CrossRef
  • Google Scholar

• 18

  Oms Om de la S (2020). WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination. WHO Newsletter. 2020. 1–13. Available from: https://apps.who.int/iris/bitstream/handle/10665/334299/WHO-2019-nCoV-SAGE_Framework- Allocation_and_prioritization-2020.1-eng.pdf (Accessed on Feb 19, 2021).

  • Google Scholar

• 19

  Ko JY Danielson ML Town M Derado G Greenlund KJ Kirley PD et al Risk Factors for Coronavirus Disease 2019 (COVID-19)–Associated Hospitalization: COVID-19–Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System. Clin Infect Dis (2021) 72(11):e695–703. 10.1093/cid/ciaa1419

  • CrossRef
  • Google Scholar

• 20

  Caballero AE Ceriello A Misra A Aschner P McDonnell ME Hassanein M et al COVID-19 in People Living with Diabetes: An International Consensus. J Diabetes Complications (2020) 34:107671. 10.1016/j.jdiacomp.2020.107671(9)

  • CrossRef
  • Google Scholar

• 21

  Anjorin AA . More Preparedness on Coronavirus Disease-2019 (COVID-19) in Nigeria. Pan Afr J Life Sci (2020) 4(1):13–6. 10.36108/pajols/0202/40(0130)

  • CrossRef
  • Google Scholar

• 22

  Taye GM Bose L Beressa TB Tefera GM Mosisa B Dinsa H et al COVID-19 Knowledge, Attitudes, and Prevention Practices Among People with Hypertension and Diabetes Mellitus Attending Public Health Facilities in Ambo, Ethiopia. Infect Drug Resist (2020) 13:4203–14. 10.2147/IDR.S283999

  • CrossRef
  • Google Scholar

• 23

  Josiah B Kantaris M . Perception of Covid-19 and Acceptance of Vaccination in Delta State Nigeria. Niger Health J21:60–86. Available from: http://www.tnhjph.com/index.php/tnhj/article/view/510 (Accessed on Sep 9, 2021).

  • Google Scholar

• 24

  Adetayo AJ Sanni BA Aborisade MO . COVID-19 Vaccine Knowledge, Attitude, and Acceptance Among Students in Selected Universities in Nigeria. Dr Sulaiman Al Habib Med J (2021) 3(4):162. 10.2991/dsahmj.k.211014.001

  • CrossRef
  • Google Scholar

• 25

  Sataloff RT Johns MM Kost KM (2004). DHS Comparative Reports. Available from: https://dhsprogram.com/publications/publication-cr6-comparative-reports.cfm (Accessed on Dec 10, 2021).

  • Google Scholar

• 26

  Martin LR Petrie KJ . Understanding the Dimensions of Anti-vaccination Attitudes: the Vaccination Attitudes Examination (VAX) Scale. Ann Behav Med (2017) 51(5):652–60. 10.1007/s12160-017-9888-y

  • CrossRef
  • Google Scholar

• 27

  Riccò M Vezzosi L Gualerzi G Bragazzi NL Balzarini F . Pertussis Immunization in Healthcare Workers Working in Pediatric Settings: Knowledge, Attitudes and Practices (KAP) of Occupational Physicians. Preliminary Results from a Web-Based Survey. J Prev Med Hyg (2017) 61:E66–75.

  • Google Scholar

• 28

  Olu-Abiodun O Abiodun O Okafor N . COVID-19 Vaccination in Nigeria: A Rapid Review of Vaccine Acceptance Rate and the Associated Factors. PLoS ONE (2022) 17(5):e0267691–10. 10.1371/journal.pone.0267691

  • CrossRef
  • Google Scholar

• 29

  Eze UA Ndoh KI Ibisola BA Onwuliri CD Osiyemi A Ude N et al Determinants for Acceptance of COVID-19 Vaccine in Nigeria. Cureus (2021) 13(11):e19801–15. 10.7759/cureus.19801

  • CrossRef
  • Google Scholar

• 30

  Tobin EA Okonofua M Adeke A Obi A . Willingness to Accept a COVID-19 Vaccine in Nigeria: A Population-Based Cross-Sectional Study. Cent Afr J Public Health (2021) 7(2):53. 10.11648/j.cajph.20210702.12

  • CrossRef
  • Google Scholar

• 31

  Uzochukwu IC Eleje GU Nwankwo CH Chukwuma GO Uzuke CA Uzochukwu CE et al COVID-19 Vaccine Hesitancy Among Staff and Students in a Nigerian Tertiary Educational Institution. Ther Adv Infect Dis (2021) 8:204993612110549–12. 10.1177/20499361211054923

  • CrossRef
  • Google Scholar

• 32

  Ilesanmi O Afolabi A Uchendu O . The Prospective COVID-19 Vaccine: Willingness to Pay and Perception of Community Members in Ibadan, 26. Nigeria. PeerJ (2021):e11153. Available from: https://peerj.com/articles/11153 (Accessed on Sep 18, 2021).

  • Google Scholar

• 33

  Adejumo OA Ogundele OA Madubuko CR Oluwafemi RO Okoye OC Okonkwo KC et al Perceptions of the COVID-19 Vaccine and Willingness to Receive Vaccination Among Health Workers in Nigeria. Osong Public Health Res Perspect (2021) 12(4):236–43. 10.24171/j.phrp.2021.0023

  • CrossRef
  • Google Scholar

• 34

  Surafel Abay EI Dawit Belew M Seleshi Ketsela B Eneyew Mengistu E Sisay Getachew L Ademe Teferi Y et al Assessment of Attitude towards COVID-19 Vaccine and Associated Factors Among Clinical Practitioners in Ethiopia: A Cross-Sectional Study. PLoS One (2022) 17. 10.1371/journal.pone.0269923

  • CrossRef
  • Google Scholar

• 35

  Sallam M , COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccin Basel (2021) 9:160. 10.3390/vaccines9020160

  • CrossRef
  • Google Scholar

• 36

  Pogue K Jensen JL Stancil CK Ferguson DG Hughes SJ Mello EJ et al Influences on Attitudes Regarding Potential Covid‐19 Vaccination in the United States. Vaccines (Basel) (2020) 8(4):E582–14. 10.3390/vaccines8040582

  • CrossRef
  • Google Scholar

• 37

  Jamison A Quinn S Freimuth V . You Don’t Trust a Government Vaccine”: Narratives of Institutional Trust and Influenza Vaccination Among African American and white Adults. Soc Sci Med (2019) 221:87–94. 10.1016/j.socscimed.2018.12.020

  • CrossRef
  • Google Scholar

• 38

  Murphy J Vallières F Bentall RP Shevlin M McBride O Hartman TK et al Psychological Characteristics Associated with COVID-19 Vaccine Hesitancy and Resistance in Ireland and the United Kingdom. Nat Commun (2021) 12(1):29–15. 10.1038/s41467-020-20226-9

  • CrossRef
  • Google Scholar

• 39

  Trent M Seale H Chughtai AA Salmon D MacIntyre CR . Trust in Government, Intention to Vaccinate and COVID-19 Vaccine Hesitancy: A Comparative Survey of Five Large Cities in the United States, United Kingdom, and Australia. Vaccine (2022) 40(17):2498–505. 10.1016/j.vaccine.2021.06.048

  • CrossRef
  • Google Scholar

• 40

  Schernhammer E Weitzer J Laubichler MD Birmann BM Bertau M Zenk L et al Correlates of COVID-19 Vaccine Hesitancy in Austria: Trust and the Government. J Public Health (Bangkok) (2021) 44:e106–e116. 10.1093/pubmed/fdab122

  • CrossRef
  • Google Scholar

• 41

  Soares P Rocha JV Moniz M Gama A Laires PA Pedro AR et al Factors Associated with COVID-19 Vaccine Hesitancy. Vaccines (Basel) (2021) 9(3):300–14. 10.3390/vaccines9030300

  • CrossRef
  • Google Scholar

• 42

  Park HK Ham JH Jang DH Lee JY Jang WM . Political Ideologies, Government Trust, and Covid-19 Vaccine Hesitancy in south korea: A Cross-Sectional Survey. Int J Environ Res Public Health (2021) 18:10655. 10.3390/ijerph182010655(20)

  • CrossRef
  • Google Scholar

• 43

  Ward JK Alleaume C Peretti-Watel P Seror V Cortaredona S Launay O et al The French Public’s Attitudes to a Future COVID-19 Vaccine: The Politicization of a Public Health Issue. Soc Sci Med (2020) 265:113414–21. 10.1016/j.socscimed.2020.113414

  • CrossRef
  • Google Scholar

• 44

  Williams L Gallant AJ Rasmussen S Brown Nicholls LA Cogan N Deakin K et al Towards Intervention Development to Increase the Uptake of COVID-19 Vaccination Among Those at High Risk: Outlining Evidence-Based and Theoretically Informed Future Intervention Content. Br J Health Psychol (2020) 25(4):1039–54. 10.1111/bjhp.12468

  • CrossRef
  • Google Scholar

• 45

  Calder PC . Nutrition and Immunity: Lessons for COVID-19. Nutr Diabetes (2021) 11(19):19–8. 10.1038/s41387-021-00165-0

  • CrossRef
  • Google Scholar

• 46

  Aman F Masood S . How Nutrition Can Help to Fight against COVID-19 Pandemic. Pak J Med Sci (2020) 36:S121–S123. 10.12669/pjms.36.COVID19-S4.2776

  • CrossRef
  • Google Scholar

• 47

  Crist C (2022). COVID Vax 5 Times More Protective Than Natural Immunity. Available from: https://www.webmd.com/vaccines/covid-19-vaccine/news/20211031/covid-vax-5-times-more-protective-than-natural-immunity (Accessed on Nov 15, 2021).

  • Google Scholar

• 48

  Hong J wan XX Yang J Zheng J Daimei S Zhou J et al Knowledge about, Attitude and Acceptance towards, and Predictors of Intention to Receive the COVID-19 Vaccine Among Cancer Patients in Eastern China: A Cross-Sectional Survey. J Integr Med (2022) 20(1):34–44. 10.1016/j.joim.2021.10.004

  • CrossRef
  • Google Scholar

• 49

  Ojewale LY Afolabi RF Ogunniyi A . COVID-19 Vaccine Attitude and its Predictors Among People Living with Chronic Health Conditions in Ibadan, Nigeria. medRxiv [Preprint] (2022). Available from: https://www.medrxiv.org/content/10.1101/2022.01.27.22269947v1

  • Google Scholar